Recent local J&J study results indicate good protection against the Delta variant. More studies are needed to assess the effectiveness of current COVID-19 vaccines against the variants. A growing body of data suggests that most vaccines stimulate enough immunity to retain substantial efficacy against most variants, especially for severe disease, hospitalisation and death. The impact of the variants on efficacy against mild disease and against infection without disease is more impacted than the more severe outcomes.[10]
